Search results
Sanders launches Senate investigation into ‘outrageously high’ pricing of Ozempic, Wegovy
CNN via AOL· 1 hour agoBoth are injectable drugs that use the active ingredient semaglutide, one of a class of medications...
KFF Analysis Finds an Estimated 1 in 4 Medicare Beneficiaries With Obesity or Overweight Could Be...
Sierra Sun Times· 2 hours agoIn a new analysis, KFF finds that 3.6 million people with Medicare could be eligible for coverage of...
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA TODAY· 4 hours agoIn the meantime, prices are extremely high for out-of-pocket purchases. Employers can't wait for ...
3.6 million Medicare recipients could qualify for Wegovy under new rule
United Press International via Yahoo News· 22 hours agoIt's possible Medicare could select semaglutide for drug price negotiation as early as 2025, given...
Novo Nordisk under Senate probe over Wegovy pricing
Seeking Alpha· 21 hours agoA key Senate committee on Wednesday announced an investigation into Novo Nordisk's (NVO) pricing of weight loss drug semaglutide in the US. Read more...
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
CNBC· 21 hours agoThe U.S. Senate has launched an investigation into the high price of Novo Nordisk's popular weight...
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks via Yahoo Finance· 4 hours agoIndustry's Current Valuation Based on the forward 12-month price-to-earnings (P/E), a commonly used...
Sanders launches investigation into ‘unacceptable’ diabetes, weight loss drug prices
The Hill via Yahoo News· 16 hours agoSen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP)...
4 Reasons Weight Loss Drugs Aren't Working for You
Verywell Health via Yahoo News· 1 day agoFor some people, those side effects are uncomfortable enough that they choose to stop the medication. Sometimes, the price tag keeps people from...
Sanders Launches Probe of 'Outrageously Overpriced' Ozempic and Wegovy | Common Dreams
CommonDreams.org· 18 hours agoThe company makes semaglutide, a glucagon-like peptide-1 (GLP-1) agonist used to treat Type 2...